Schedule 13D ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Security class unavailable · CUSIP: 55910K108
Event date: 2020-06-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 41,171,251
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-006396
- Form type
- SC 13D
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Jul 14, 2020
- Reporting period
- Jun 29, 2020
- Description
- Schedule 13D beneficial ownership